from
EIAab
Dr. Michael Karin, a professor at the University of California San Diego School of Medicine, found through mouse and human clinical specimens that caspase-2, a proteolytic enzyme, is a key driver of non-alcoholic steatohepatitis NASH.In the latest study, the researchers first stimulated NASH-like diseases by combining ...